Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma
NCT02728349
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
Chlorogenic acid
Sponsor
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd
Collaborators
[object Object]